STRATA Skin Sciences, Inc.

Contributing Author

Recent Articles by STRATA Skin Sciences, Inc.

Feb-19	STRATA Skin Sciences Confirms Nasdaq Delisting GlobeNewswire
Feb-18	Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC Excimer Laser GlobeNewswire
Feb-17	STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis GlobeNewswire
Dec-09	STRATA Skin Sciences Showcases XTRAC and TheraclearX at TeraCILAD 2025 - Reports Early Adoption Momentum in Mexico GlobeNewswire
Nov-13	STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update GlobeNewswire
Nov-06	STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion GlobeNewswire
Nov-05	STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update GlobeNewswire
Oct-28	STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear in Mexico and First Commercial Placements GlobeNewswire
Oct-20	STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek GlobeNewswire
Oct-14	Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides GlobeNewswire
Oct-03	Marking Eczema Awareness Month - Clinical Research Validates Strata Skin Sciences' XTRAC Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis GlobeNewswire
Sep-30	STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC Excimer Laser Treatment Combined with a Topical Drug in Psoriasis GlobeNewswire
Sep-22	New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences' Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation of Personalized Medicine Approach GlobeNewswire
Sep-04	STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering GlobeNewswire
Sep-04	STRATA Skin Sciences' Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements GlobeNewswire
Sep-03	STRATA Skin Sciences Announces Pricing of $2.42 Million Registered Direct Offering of Common Stock Priced At-Market Under Nasdaq Rules GlobeNewswire
Sep-02	STRATA Skin Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference GlobeNewswire
Sep-02	STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion into New Indications Like Vitiligo and Other Auto-Immune Skin Conditions GlobeNewswire
Aug-13	STRATA Skin Sciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update GlobeNewswire
Aug-07	STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients GlobeNewswire
Jul-31	STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update GlobeNewswire
May-19	STRATA Skin Sciences Announces Historic Expansion of CPT Codes for Reimbursement of 308nm Excimer Laser Treatments, Unlocking Access for Millions with Inflammatory and Auto-Immune Skin Diseases GlobeNewswire
May-14	STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update GlobeNewswire
May-08	STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference GlobeNewswire
May-07	STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update GlobeNewswire

STRATA Skin Sciences, Inc.

Recent Articles by STRATA Skin Sciences, Inc.

Upgrade your Finviz experience